Long-acting injectable treatment highly effective in European cohort studies
PD-1 inhibitor budigalimab may delay viral rebound
HIV services in Ukraine resilient but starting to feel the strain
Some women in France are using PrEP, but only transgender women tend to stay on it
Body mass index is sufficient to predict diabetes or metabolic syndrome, Italian study finds
Increasing and changing pattern of treatment switches among people with HIV
Reduced-drug treatment becoming common in Paris
Dolutegravir may increase blood clotting affecting stroke and heart attack risk, early findings warn
Intermittent dosing on HIV dual therapy leads to higher rate of treatment failure
